Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 242 clinical trials
Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents

The objective is to, among obese adolescents, study impact of regular physical activity or metformin therapy on nocturnal blood pressure and related cardiovascular disease risk factors.

  • 4 views
  • 07 Nov, 2020
  • 1 location
Metformin Glycinate Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.

The purpose of this study is to evaluate the efficacy and safety of the metformin glycinate and standard treatment of the hospital in hospitalized patients with Severe Acute Respiratory Syndrome

  • 0 views
  • 26 Jan, 2021
  • 1 location
Glucophage Extended Release (GXR) 500 Milligrams (mg) Korea Bioequivalence (BE) Study

The purpose of this study is to assess bioequivalence of newly developed Glucophage XR reduced mass tablet (metformin hydrochloride 500 milligrams (mg) test tablet) and marketed Glucophage XR

  • 0 views
  • 07 Mar, 2021
  • 1 location
Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and

  • 0 views
  • 26 Jan, 2021
Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

and biomarkers in metformin-treated T2DM patients.

  • 0 views
  • 26 Jan, 2021
  • 1 location
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

This is a double-blind, placebo-controlled study in adults with non-alcoholic steatohepatitis and Type 2 Diabetes Mellitis on stable dose of metformin monotherapy. Participants will be treated

type 2 diabetes mellitus
liver disease
metformin
glycosylated hemoglobin
mri-pdff
  • 224 views
  • 18 Feb, 2021
  • 144 locations
The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine

In Part 1, subjects will be administered thiamine, thiamine with metformin, and thiamine with trimethoprim. Part 2 will expand on Part 1 and subjects will be administered thiamine and thiamine

  • 1 views
  • 26 Jan, 2021
  • 1 location
Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

of a 4-month polychemotherapy (metformin+pioglitazone+sitagliptin+empagliflozin) regimen vs standard care in patients with newly diagnosed T2DM by an open label, pragmatic RCT. Mechanisms of action

  • 0 views
  • 26 Jan, 2021
  • 1 location
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology

Current anti-diabetic treatment fails to stop the progressive course of the disease. Recent studies have revealed a surprisingly high variability in the diabetic phenotype. The investigators propose that anti-diabetic treatment should ideally target the underlying pathophysiology of each individual patient. The investigators will therefore test whether the effect of two …

  • 0 views
  • 25 Jan, 2021
  • 1 location
The Effect of Sitagliptin on Hypertension Arterial Stiffness Oxidative Stress and Inflammation

Recently a new category of antihyperglycemic therapy aiming to modulate the incretin system has emerged. These drugs induce insulin secretion without inducing hypoglycemia. The effect of the incretin modulators drugs on hypertension, arterial stiffness, inflammation and oxidative stress parameters have not been fully investigated yet.GLP-1 analogue has been suggested to …

type 2 diabetes mellitus
metformin
heart disease
incretins
hypoglycemic agents
  • 11 views
  • 07 Nov, 2020
  • 1 location